In the ever-evolving landscape of healthcare, the integration of technology is paramount, particularly in weight management.

The Food and Drug Administration approved the first-ever glucose monitoring system specifically for weight management from the startup Signos, a new option for Americans to manage their weight. Any ...

CGM. It stands for Continuous Glucose Monitoring and it’s a technology being used as a next generation tool in weight management. CGM has historically been used by people with diabetes to help monitor ...

Utilization of GLP-1s, short for glucagon-like peptide 1 agonists, has been building as the drugs, originally approved for diabetes, are used more frequently for weight loss. Insurers have been ...

A recent BMC Public Health study analyzes self-monitoring data from Chinese adults who participated in a group weight loss intervention using a mixed-methods approach. Study: Why more successful? An ...

Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...

The FDA has approved Signos, an AI-powered app that uses continuous glucose monitoring to guide weight loss and personalized nutrition. Cheaper than GLP-1 drugs, Signos offers real-time feedback on ...